Texas Children’s cancer and hematology center, transitioning to Kinder Children’s Cancer Center, is one of the nation’s largest pediatric cancer and hematology programs, recording more than 90,000 outpatient visits and 5,500 new cancer and hematology patients in 2025, including more than 500 children newly diagnosed with cancer. Ranked No. 9 nationally in pediatric cancer by U.S. News & World Report for 2025-26, the program has remained among the nation’s top 10 for nine consecutive years. It offers more than 250 active therapeutic clinical trials and is internationally recognized for leadership in stem cell transplantation, cellular immunotherapy and gene therapy. In 2026, Texas Children’s and Houston-based The University of Texas MD Anderson Cancer Center launched Kinder Children’s Cancer Center, a first-of-its-kind joint venture with a mission to end childhood cancer. Supported by a $150 million gift from the Kinder Foundation, plans include a purpose-built comprehensive cancer center in the Texas Medical Center designed to expand access to specialized care and clinical trials and accelerate pediatric cancer research and drug development.
